You just read:

Alcyone Lifesciences Enters into a Feasibility Study Agreement with Pfizer to Evaluate Alcyone's proprietary Pulsar™ Advanced Intrathecal Precision Delivery Platform Technology for use in Gene Therapy Targeting Central Nervous System Disorders

News provided by

Alcyone Lifesciences, Inc.

Jun 29, 2017, 08:30 ET